Global Pregnancy Point of Care Testing Market Research Report 2022
Pregnancy tests are point of care tests used to qualitatively detect the presence of reproductive hormones, such as Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) hormone.
Due to the COVID-19 pandemic, the global Pregnancy Point of Care Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Pregnancy Point of Care Testing market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Pregnancy Point of Care Testing landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
LH Urine Test accounting for % of the Pregnancy Point of Care Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmacies & Drugstores segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Pregnancy Point of Care Testing include Swiss Precision Diagnostics, bioMerieux, Church & Dwight, Rohto, NFI Consumer Healthcare, Wondfo, Egens Biotech, Arax and Quidel Corporation, etc. In terms of revenue, the global 3 largest players have a % market share of Pregnancy Point of Care Testing in 2021.
This report focuses on Pregnancy Point of Care Testing volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Pregnancy Point of Care Testing market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Pregnancy Point of Care Testing Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
LH Urine Test
FSH Urine Test
HCG Blood Test
HCG Urine Test
Segment by Application
Pharmacies & Drugstores
Gynecology & Fertility Clinics
Hypermarkets & Supermarkets
Online Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Swiss Precision Diagnostics
bioMerieux
Church & Dwight
Rohto
NFI Consumer Healthcare
Wondfo
Egens Biotech
Arax
Quidel Corporation
Runbio Biotech
Easy Healthcare
CIGA Healthcare
Biosynex
NOW Diagnostics
NG Biotech
Ulti med Products
EKF Diagnostics Holdings
Due to the COVID-19 pandemic, the global Pregnancy Point of Care Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Pregnancy Point of Care Testing market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Pregnancy Point of Care Testing landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
LH Urine Test accounting for % of the Pregnancy Point of Care Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmacies & Drugstores segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Pregnancy Point of Care Testing include Swiss Precision Diagnostics, bioMerieux, Church & Dwight, Rohto, NFI Consumer Healthcare, Wondfo, Egens Biotech, Arax and Quidel Corporation, etc. In terms of revenue, the global 3 largest players have a % market share of Pregnancy Point of Care Testing in 2021.
This report focuses on Pregnancy Point of Care Testing volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Pregnancy Point of Care Testing market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Pregnancy Point of Care Testing Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
LH Urine Test
FSH Urine Test
HCG Blood Test
HCG Urine Test
Segment by Application
Pharmacies & Drugstores
Gynecology & Fertility Clinics
Hypermarkets & Supermarkets
Online Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Swiss Precision Diagnostics
bioMerieux
Church & Dwight
Rohto
NFI Consumer Healthcare
Wondfo
Egens Biotech
Arax
Quidel Corporation
Runbio Biotech
Easy Healthcare
CIGA Healthcare
Biosynex
NOW Diagnostics
NG Biotech
Ulti med Products
EKF Diagnostics Holdings
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
